Contraception for Women With Psychiatric Disorders
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Mental health care for women includes decision support to prepare for major life events, including preconception planning for treatment during pregnancy and the postpartum period. The authors discuss contraceptive choices and their effectiveness, side effects, and impact on psychiatric symptoms. The Centers for Disease Control and Prevention's recommendations, Medical Eligibility Criteria for Contraceptive Use, provided the structure for review of contraceptive choices. METHODS: A search of PsycINFO, PubMed, Embase, and Scopus was conducted for publications on the management of contraception for women with mental illness. Publications were selected if they included, based on the authors' consensus, data supporting evidence-based care important for psychiatrists who treat women desiring contraceptives. RESULTS: The majority of women choose combined oral contraceptives. Although long-acting reversible contraceptives (implants, intrauterine devices) are associated with low failure rates, favorable safety profiles, rapid return to fertility after removal, and few contraindications, they are chosen by only 14% of women. All methods are acceptable for women with depression, although medical comorbidities may dictate a specific type. The impact of hormonal contraceptives on the risk for depression is controversial; however, clinical studies and randomized placebo-controlled trials of women with psychiatric disorders have generally reported similar or lower rates of mood symptoms in hormonal contraceptive users compared with nonusers. Although interactions between psychotropic drugs and contraceptives are rare, clozapine, anticonvulsants, and St. John's Wort are exceptions. CONCLUSIONS: Proactive management of mental illness, contraception, and pregnancy improves a woman's capacity to function and optimizes her mental and reproductive health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Hormonal Contraception With Depression
Skovlund, C. W., Mørch, L. S., Kessing, L. V., & Lidegaard, Ø. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2387 · Cited by 675
Practice Bulletin No. 110: Noncontraceptive Uses of Hormonal Contraceptives
(2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181cb50b5 · Cited by 208
Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review
Berry-Bibee, E. N., Kim, M.-J., Simmons, K. B., Tepper, N. K., Riley, H. E. M., Pagano, H. P., & Curtis, K. M. (2016) · Contraception · doi:10.1016/j.contraception.2016.07.011 · Cited by 52
Cited by
Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic
Han, B., Compton, W. M., Einstein, E. B., Elder, E., & Volkow, N. D. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4523 · Cited by 127
Prioritizing Maternal Mental Health in Addressing Morbidity and Mortality
Wisner, K. L., Murphy, C., & Thomas, M. M. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5648 · Cited by 91
Self-citationDepressive Symptoms and Control of Emotions among Polish Women with Polycystic Ovary Syndrome
Pokora, K., Kowalczyk, K., Wikarek, A., Rodak, M., Pędrys, K., Wójtowicz, M., Wyskida, K., & Jonderko, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416871 · Cited by 14
“There are reports of both improvement and no improvement after the use of these drugs in depressive symptoms among women with PCOS [48].”
Background
Metadata
- Authors
- McCloskey, L. R., Wisner, K. L., Cattan, M. K., Betcher, H. K., Stika, C. S., & Kiley, J. W.
- Venue
- American Journal of Psychiatry
- Published
- 2021-03-01
- Volume
- 178
- Issue
- 3
- Pages
- 247-255
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W3106341709
- Cited by
- 75
- References
- 3
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.